Omegaven 10% (DrugBank: -)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 96 | Crohn disease | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02349594 (ClinicalTrials.gov) | January 2014 | 16/1/2015 | Immune Modulation by Parenteral Fish Oil in Patients With Crohn's Disease | Modulation of Immune Function by Parenteral Fish Oil in Patients With Crohn's Disease and High Inherent Tumor Necrosis Factor-alpha Production: a Randomized, Single Blinded, Cross-over Study | Crohn Disease | Drug: Omegaven 10%;Drug: Intralipid 20% | Radboud University | NULL | Completed | 18 Years | 70 Years | Both | 6 | Phase 4 | Netherlands |